News

Inspicos achieves major win at the EPO

During oral proceedings before the EPO’s Boards of Appeal on 23 February 2017, Inspicos obtained a major win on behalf of a leading international manufacturer of healthcare devices. The oral proceedings concluded more than 10 years of opposition and appeal. On the client’s behalf, Inspicos successfully defended the validity of the opposed patent on the ...

read more

Anna Lövqvist appointed a partner

We proudly announce that European Patent Attorney Anna Lövqvist is now a shareholder and partner at Inspicos P/S. Anna joined Inspicos as an associate in 2009. Being part of the Biotechnology and Chemistry group, she primarily advises innovator companies in the field of biotechnology and biopharmaceuticals, working, e.g., with patenting and freedom-to-operate analyses of immunotherapeutic ...

read more

Ranking results 2017

As in previous years, Inspicos has been ranked as a highly recommended firm in the 2017 edition of IAM’s Patent 1000 – The World’s Leading Patent Practitioners. On the basis of market surveys, the following testimonial is provided by IAM’s editors: Prosecution powerhouse Inspicos blazes a trail in oppositions, appeals and contentious support. Its percipient ...

read more

What does Brexit mean to your IP in Europe?

Ulla Klinge reports. The short answer is there is no immediate impact. Following the referendum result the British Parliament will now consider how and when to proceed. The UK’s exit from the EU will be negotiated over at least the next two years, and during that time the UK will remain a member of the ...

read more